Stock listing

BNGO Stock Price, News, Filings & Events — Bionano Genomics, Inc.

Selected listing: BNGO · BMV · MXN · MX

This page tracks Bionano Genomics, Inc.'s BNGO:BMV listing on BMV in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BNGO:BMV. BNGO:BMV is the stock-level entry point for investors researching Bionano Genomics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bionano Genomics, Inc. (ticker: BNGO) is a public company based in the United States, specializing in genomic analysis technology. The company has a market capitalization of approximately $13.08 million. Bionano focuses on providing innovative solutions for genome mapping and analysis, aiming to enhance research and clinical applications in genomics.

BNGO:BMVMXNMXUpdated August 28, 2026
Bionano Genomics, Inc. logo
Ticker
BNGO:BMV
Asset type
Stock
Market cap
$13.8M
Sector
Health Technology
Industry
Biotechnology
Exchange
BMV
Currency
MXN

Bionano Genomics, Inc. BNGO:BMV stock context

This page tracks Bionano Genomics, Inc.'s BNGO:BMV listing on BMV in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BNGO:BMV. BNGO:BMV is the stock-level entry point for investors researching Bionano Genomics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bionano Genomics, Inc. (ticker: BNGO) is a public company based in the United States, specializing in genomic analysis technology. The company has a market capitalization of approximately $13.08 million. Bionano focuses on providing innovative solutions for genome mapping and analysis, aiming to enhance research and clinical applications in genomics.

Latest news from Bionano Genomics, Inc.

All Bionano Genomics, Inc. news →

Bionano Genomics, Inc. earnings calls

Research Bionano Genomics, Inc.

Alternate listings